Journal
CELL CYCLE
Volume 8, Issue 8, Pages 1145-1147Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.8.8.8200
Keywords
JNK1; HCC; apoptosis; epigenetics
Categories
Funding
- National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention of the USA [970036]
Ask authors/readers for more resources
Hepatocellular Carcinoma (HCC) is the fourth most common neoplasm and the third leading cause of cancer-related death worldwide. Tremendous effort has been made during the past several years in understanding the molecular mechanisms governing the pathogenesis and progression of HCC. Recent studies indicated that c-Jun N-terminal kinase 1 (JNK1), but not JNK2, played pivotal role in the expression of the key signature genes and the prognostic outcomes of HCC. Accordingly, we believe that targeting JNK1 is not only mechanistically sound but also clinically feasible for the treatment of HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available